<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04585178</url>
  </required_header>
  <id_info>
    <org_study_id>2020_0050</org_study_id>
    <nct_id>NCT04585178</nct_id>
  </id_info>
  <brief_title>Screening for Postoperative Complications by Continuous Monitoring</brief_title>
  <acronym>Biobeat-Postop</acronym>
  <official_title>Detection of Postoperative Complications Through Continuous Monitoring Using the Biobeat Patch</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brief Summary: Post-operative morbidity remains a reality as shown by the International&#xD;
      Surgical Outcomes Study published in 2016 and 2019 and by several recent publications which&#xD;
      focus mainly on hypotension and cardio-vascular complications. Other complications, such as&#xD;
      respiratory depression, are less often studied. The hypothesis is that this connected patch&#xD;
      could be used in surgical departments to detect a postoperative complication.&#xD;
&#xD;
      Biobeat Technologies Ltd has developed a sensor which continuously records the&#xD;
      photoplethysmographic waveform and allows the calculation of several physiological&#xD;
      parameters: heart rate (HR), oxygen saturation (SpO2), systolic blood pressure (SBP),&#xD;
      diastolic blood pressure (DBP), stroke volume (SV), cardiac output (CO), cardiac index (CI),&#xD;
      systemic vascular resistance (SVR), respiratory rate (RR), and temperature.&#xD;
&#xD;
      The objective of this study is the quantification of hemodynamic, respiratory and temperature&#xD;
      abnormalities detected by routine monitoring (routine nursing follow-up) and continuous&#xD;
      monitoring by the Biobeat patch during the first 72 postoperative hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with a hemodynamic abnormality using the data obtained using the Biobeat patch.</measure>
    <time_frame>72 hours</time_frame>
    <description>A hemodynamic abnormality is defined as:&#xD;
an mean Blood Pressure (MBP) &lt; 70 mmHg&#xD;
or an MBP &lt; 65 mmHg&#xD;
or an MBP &lt; 80% of the value measured during the preanesthetic consultation&#xD;
or an MBP &lt; 70% of the value measured during the preanesthetic consultation&#xD;
or an MBP &lt; 80% of the value measured in the OR before the induction of anesthesia&#xD;
or an MBP &lt; 70% of the MBP measured in the OR before the induction of anesthesia&#xD;
or an MBP &gt; 100 mmHg&#xD;
or an MBP &gt; 110 mmHg&#xD;
or an MBP &gt; 120 mmHg&#xD;
or an MBP &gt; 130 mmHg&#xD;
or a MBP &gt; 120% of the MBP measured during the preanesthetic consultation&#xD;
or a MBP &gt; 130% of the MBP measured during the preanesthetic consultation&#xD;
or a MBP &gt; 120% of the MBP measured in the OR before induction of anesthesia&#xD;
or a MBP &gt; 130% of the MBP measured in the OR before induction of anesthesia&#xD;
or a heart rate &lt; 40/min&#xD;
or a heart rate &gt; 100/min&#xD;
or a rhythm disorder</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with hypotension detected by the routine nursing follow-up.</measure>
    <time_frame>72 hours</time_frame>
    <description>A hemodynamic abnormality is defined as:&#xD;
An MBP &lt; 70 mmHg&#xD;
or an MBP &lt; 65 mmHg&#xD;
or an MBP &lt; 80% of the value measured during the preanesthetic consultation&#xD;
or an MBP &lt; 70% of the value measured during the preanesthetic consultation&#xD;
or an MBP &lt; 80% of the value measured in the OR before the induction of anesthesia&#xD;
or an MBP &lt; 70% of the MBP measured in the OR before the induction of anesthesia&#xD;
or an MBP &gt; 100 mmHg&#xD;
or an MBP &gt; 110 mmHg&#xD;
or an MBP &gt; 120 mmHg&#xD;
or an MBP &gt; 130 mmHg&#xD;
or an MBP &gt; 120% of the MBP measured during the preanesthetic consultation&#xD;
or an MBP &gt; 130% of the MBP measured during the preanesthetic consultation&#xD;
or an MBP &gt; 120% of the MBP measured in the OR before induction of anesthesia&#xD;
or an MBP &gt; 130% of the MBP measured in the OR before induction of anesthesia&#xD;
or a heart rate &lt; 40/min&#xD;
or a heart rate &gt; 100/min&#xD;
or a rhythm disorder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with a postoperative respiratory abnormality using the data obtained using the Biobeat patch.</measure>
    <time_frame>72 hours</time_frame>
    <description>A postoperative respiratory abnormality is defined as:&#xD;
a breathing rate &lt; 8/min&#xD;
or a breathing rate &gt; 20/min&#xD;
or arterial oxygen saturation &lt; 95%&#xD;
or arterial oxygen saturation ≤ 92%&#xD;
or arterial oxygen saturation ≤ 90%&#xD;
or arterial oxygen saturation ≤ 85%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with a postoperative respiratory abnormality detected by the routine nursing follow-up.</measure>
    <time_frame>72 hours</time_frame>
    <description>A postoperative respiratory abnormality is defined as:&#xD;
a breathing rate &lt; 8/min&#xD;
or a breathing rate &gt; 20/min&#xD;
or arterial oxygen saturation &lt; 95%&#xD;
or arterial oxygen saturation ≤ 92%&#xD;
or arterial oxygen saturation ≤ 90%&#xD;
or arterial oxygen saturation ≤ 85%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with a temperature abnormality using the data obtained using the Biobeat patch.</measure>
    <time_frame>72 hours</time_frame>
    <description>A temperature abnormality is defined as:&#xD;
a temperature ≤ 36.8 °C&#xD;
or a temperature ≥ 38°C&#xD;
or a temperature ≥ 39°C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantify and compare the frequency of temperature abnormality detected by the routine nursing follow-up.</measure>
    <time_frame>72 hours</time_frame>
    <description>temperature abnormality is defined as:&#xD;
a temperature ≤ 36.8 °C&#xD;
or a temperature ≥ 38°C&#xD;
or a temperature ≥ 39°C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concerning the Biobeat patch, frequency of artifacts or of absence of data</measure>
    <time_frame>72 hours</time_frame>
    <description>An artefact is defined as&#xD;
a value that is &gt; 50% different from the previous value, unless it is followed by a value equal to ± 25%;&#xD;
or a value that is outside the physiologically plausible range (heart rate &lt; 5 or &gt; 250 bpm, systolic blood pressure &lt; 20 mm Hg or &gt; 300 mm Hg or lower than diastolic pressure plus 5 mm Hg, diastolic blood pressure &lt; 5 mm Hg or &gt; 225 mm Hg, change in SpO2 ≥ 8% between two consecutive measurements, breathing rate &lt; 3 or &gt; 125 breaths per minute, change in skin temperature ≥ 1° between two consecutive measurements).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Collection of postoperative complications that occurred during the monitoring period</measure>
    <time_frame>72 hours</time_frame>
    <description>A postoperative complication will be classified according to the classification of Dindo and Clavien (Dindo, Demartines et al. 2004).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of patients' tolerance to wearing the Biobeat device</measure>
    <time_frame>72 hours</time_frame>
    <description>4- point Likert scale (from 0 = intolerable to 4 = no problem at all)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Surgery--Complications</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The population recruited corresponds to patients undergoing major surgery (digestive,&#xD;
        gynaecological or urological surgery) for which post-operative vital signs monitoring is&#xD;
        required.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient 18 years of age or older&#xD;
&#xD;
          -  Patient undergoing major digestive, gynecological, orthopedic or urological surgery&#xD;
             (expected duration of surgery greater than 2 hours).&#xD;
&#xD;
          -  Predictable postoperative hospitalization duration ≥ 3 nights&#xD;
&#xD;
          -  Patient with a Health Insurance plan&#xD;
&#xD;
          -  Not having opposed participation in the research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with significant deformity, swelling, irritation or with localized infection,&#xD;
             ulceration or skin lesions on the torso&#xD;
&#xD;
          -  Patient with a subcutaneous electronic pacemaker implant.&#xD;
&#xD;
          -  Patient with a CT or MRI scan already scheduled for the first three days&#xD;
             postoperatively&#xD;
&#xD;
          -  Patient suffering from tremors or convulsions&#xD;
&#xD;
          -  Patient with a torso tattoo&#xD;
&#xD;
          -  Patient with significant chest hairiness&#xD;
&#xD;
          -  Patient with a known allergy to metals, plastics and silicone&#xD;
&#xD;
          -  Patient deprived of liberty or under guardianship&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Paternot, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Foch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisabeth Huilier-Ammar, Dr</last_name>
    <phone>+33 01 46 25 11 75</phone>
    <email>drci-promotion@hopital-foch.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexis Paternot, Dr</last_name>
    <phone>+33 01 46 25 59 83</phone>
    <email>a.paternot@hopital-foch.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupe hospitalier Paris Saint-Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal ALFONSI, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis PATERNOT, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Liem VGB, Hoeks SE, Mol KHJM, Potters JW, Grüne F, Stolker RJ, van Lier F. Postoperative Hypotension after Noncardiac Surgery and the Association with Myocardial Injury. Anesthesiology. 2020 Sep;133(3):510-522. doi: 10.1097/ALN.0000000000003368.</citation>
    <PMID>32487822</PMID>
  </reference>
  <reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </reference>
  <reference>
    <citation>International Surgical Outcomes Study (ISOS) group. Prospective observational cohort study on grading the severity of postoperative complications in global surgery research. Br J Surg. 2019 Jan;106(2):e73-e80. doi: 10.1002/bjs.11025.</citation>
    <PMID>30620066</PMID>
  </reference>
  <reference>
    <citation>Turan A, Chang C, Cohen B, Saasouh W, Essber H, Yang D, Ma C, Hovsepyan K, Khanna AK, Vitale J, Shah A, Ruetzler K, Maheshwari K, Sessler DI. Incidence, Severity, and Detection of Blood Pressure Perturbations after Abdominal Surgery: A Prospective Blinded Observational Study. Anesthesiology. 2019 Apr;130(4):550-559. doi: 10.1097/ALN.0000000000002626.</citation>
    <PMID>30875354</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surgery</keyword>
  <keyword>vital signs</keyword>
  <keyword>continuous monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Dryad Repository</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

